Thao Thi Dang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thao Thi Dang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Sung Hoon Back
Department of Electrical, Electronic and Computer Engineering, University of Ulsan, Ulsan, 44610, Republic of Korea
5 shared publications - Kyo-In Koo
Department of Electrical, Electronic and Computer Engineering, University of Ulsan, Ulsan 44610, Republic of Korea
4 shared publications - Van Thuy Duong
Electrical, Electronic and Computer Engineering, University of Ulsan, 93 Daehak-ro, Nam-gu, Ulsan, 44610, Korea (the Republic of)
4 shared publications - Chanh Trung Nguyen
Department of Electrical, Electronic and Computer Engineering, University of Ulsan, Ulsan, 44610, Republic of Korea
3 shared publications - Huu Lam Phan
University of Ulsan, 93 Daehak-ro, Nam-gu, Ulsan, Ulsan, 44610, Korea (the Republic of)
3 shared publications - Jong-Mo Seo
Department of Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea
3 shared publications
Latest Publications
- Open Access
Development of a Novel Method to Detect AAV Vector Integration
AAV integration has become an important safety consideration in gene therapy. However, accurately determining integration sites remains challenging due to biases introduced by library preparation methods, sequencing technologies, and bioinformatic pipelines. In this study, we developed a PCR-free amplification based on a CRISPR-Cas9 cleavage strategy for AAV DNA that overcomes the limitations of PCR amplification imposed by the ITR structure. When combined with long-read nanopore sequencing, this CRISPR-Cas9-based workflow preserves native AAV integration states and enables unbiased detection of integration junctions. We used AAV-transduced HeLa single-cell clones to evaluate the performance of this approach. To confirm integration site identification, AAV integration junctions were also detected using a probe hybridization capture strategy followed by Illumina short-read sequencing. Integration junctions identified by both methods were further confirmed by PCR. The results showed strong consistency between the two approaches in accurately identifying AAV integration sites in each clone. Overall, these findings demonstrate that the CRISPR-Cas9-enabled, PCR-free long-read sequencing workflow provides a promising tool for characterizing AAV integration events.
Open AccessDevelopment of a Novel Method to Detect AAV Vector Integration
AAV integration has become an important safety consideration in gene therapy. However, accurately determining integration sites remains challenging due to biases introduced by library preparation methods, sequencing technologies, and bioinformatic pipelines. In this study, we developed a PCR-free amplification based on a CRISPR-Cas9 cleavage strategy for AAV DNA that overcomes the limitations of PCR amplification imposed by the ITR structure. When combined with long-read nanopore sequencing, this CRISPR-Cas9-based workflow preserves native AAV integration states and enables unbiased detection of integration junctions. We used AAV-transduced HeLa single-cell clones to evaluate the performance of this approach. To confirm integration site identification, AAV integration junctions were also detected using a probe hybridization capture strategy followed by Illumina short-read sequencing. Integration junctions identified by both methods were further confirmed by PCR. The results showed strong consistency between the two approaches in accurately identifying AAV integration sites in each clone. Overall, these findings demonstrate that the CRISPR-Cas9-enabled, PCR-free long-read sequencing workflow provides a promising tool for characterizing AAV integration events.
- 19 September 2024
- Published by Elsevier in Biomaterials
- Vol. 314, 122840
Direct extrusion of multifascicle prevascularized human skeletal muscle for volumetric muscle loss surgery
- 19 September 2024
- Published by Elsevier in Biomaterials
- Vol. 314, 122840
Direct extrusion of multifascicle prevascularized human skeletal muscle for volumetric muscle loss surgery
- Open Access
Direct extrusion of multifascicle prevascularized human skeletal muscle for volumetric muscle loss surgery
Volumetric skeletal muscle injuries are prevalent, highlighting the imperative need for scaffolds to facilitate the healing process of such wounds. Human skeletal muscle is composed of multiple fascicles, which are parallel bundles of muscle fibres surrounded by a layer of connective tissue that contains blood vessels and nerves. Replicating these structures presents a considerable challenge. Here, we developed a method to fabricate multifascicle human skeletal muscle scaffolds that mimic the natural structure of human skeletal muscle bundles using a seven-barrel nozzle. To form the core material to generate the fascicle structure, human skeletal myoblasts were encapsulated in Matrigel with calcium chloride. Meanwhile, to create the shell that plays a role as the connective tissue structure, human fibroblasts and human umbilical vein endothelial cells within a mixture of porcine muscle decellularized extracellular matrix and sodium alginate at a 95:5 ratio was used. We assessed four types of extruded scaffolds monolithic-monoculture (Mo-M), monolithic-coculture (Mo-C), multifascicle-monoculture (Mu-M), and multifascicle-coculture (Mu-C) to determine the structural effect of muscle mimicking scaffold. The Mu-C scaffold demonstrated cell proliferation, differentiation, vascularization, mechanical properties, and functionality that were superior to those of the other scaffolds. Furthermore, in an in vivo mouse model of volumetric muscle loss, the Mu-C scaffold effectively regenerated the tibialis anterior muscle defect, demonstrating its potential for volumetric muscle transplantation. The multibarrel nozzle device was applied to create functional Mu-C muscle scaffolds that structurally mimicked human skeletal muscle. Our nozzle will be further used to produce other volumetric functional tissues, such as tendons and peripheral nerves.
Open AccessDirect extrusion of multifascicle prevascularized human skeletal muscle for volumetric muscle loss surgery
Volumetric skeletal muscle injuries are prevalent, highlighting the imperative need for scaffolds to facilitate the healing process of such wounds. Human skeletal muscle is composed of multiple fascicles, which are parallel bundles of muscle fibres surrounded by a layer of connective tissue that contains blood vessels and nerves. Replicating these structures presents a considerable challenge. Here, we developed a method to fabricate multifascicle human skeletal muscle scaffolds that mimic the natural structure of human skeletal muscle bundles using a seven-barrel nozzle. To form the core material to generate the fascicle structure, human skeletal myoblasts were encapsulated in Matrigel with calcium chloride. Meanwhile, to create the shell that plays a role as the connective tissue structure, human fibroblasts and human umbilical vein endothelial cells within a mixture of porcine muscle decellularized extracellular matrix and sodium alginate at a 95:5 ratio was used. We assessed four types of extruded scaffolds monolithic-monoculture (Mo-M), monolithic-coculture (Mo-C), multifascicle-monoculture (Mu-M), and multifascicle-coculture (Mu-C) to determine the structural effect of muscle mimicking scaffold. The Mu-C scaffold demonstrated cell proliferation, differentiation, vascularization, mechanical properties, and functionality that were superior to those of the other scaffolds. Furthermore, in an in vivo mouse model of volumetric muscle loss, the Mu-C scaffold effectively regenerated the tibialis anterior muscle defect, demonstrating its potential for volumetric muscle transplantation. The multibarrel nozzle device was applied to create functional Mu-C muscle scaffolds that structurally mimicked human skeletal muscle. Our nozzle will be further used to produce other volumetric functional tissues, such as tendons and peripheral nerves.
- 22 September 2023
- Published by IOP Publishing in Biofabrication
- Vol. 15 (4) , 045022
Double-layered blood vessels over 3 mm in diameter extruded by the inverse-gravity technique
One of the most promising techniques for treating severe peripheral artery disease is the use of cellular tissue-engineered vascular grafts (TEVGs). This study proposes an inverse-gravity (IG) extrusion technique for creating long double-layered cellular TEVGs with diameters over 3 mm. A three-layered coaxial laminar hydrogel flow in an 8 mm-diameter pipe was realised simply by changing the extrusion direction of the hydrogel from being aligned with the direction of gravity to against it. This technique produced an extruded mixture of human aortic smooth muscle cells (HASMCs) and type-I collagen as a tubular structure with an inner diameter of 3.5 mm. After a 21 day maturation period, the maximal burst pressure, longitudinal breaking force, and circumferential breaking force of the HASMC TEVG were 416 mmHg, 0.69 N, and 0.89 N, respectively. The HASMC TEVG was endothelialised with human umbilical vein endothelial cells to form a tunica intima that simulated human vessels. Besides subcutaneous implantability on mice, the double-layered blood vessels showed a considerably lower adherence of platelets and red blood cells once exposed to heparinised mouse blood and were considered nonhaemolytic. The proposed IG extrusion technique can be applied in various fields requiring multilayered materials with large diameters.
- 22 September 2023
- Published by IOP Publishing in Biofabrication
- Vol. 15 (4) , 045022
Double-layered blood vessels over 3 mm in diameter extruded by the inverse-gravity technique
One of the most promising techniques for treating severe peripheral artery disease is the use of cellular tissue-engineered vascular grafts (TEVGs). This study proposes an inverse-gravity (IG) extrusion technique for creating long double-layered cellular TEVGs with diameters over 3 mm. A three-layered coaxial laminar hydrogel flow in an 8 mm-diameter pipe was realised simply by changing the extrusion direction of the hydrogel from being aligned with the direction of gravity to against it. This technique produced an extruded mixture of human aortic smooth muscle cells (HASMCs) and type-I collagen as a tubular structure with an inner diameter of 3.5 mm. After a 21 day maturation period, the maximal burst pressure, longitudinal breaking force, and circumferential breaking force of the HASMC TEVG were 416 mmHg, 0.69 N, and 0.89 N, respectively. The HASMC TEVG was endothelialised with human umbilical vein endothelial cells to form a tunica intima that simulated human vessels. Besides subcutaneous implantability on mice, the double-layered blood vessels showed a considerably lower adherence of platelets and red blood cells once exposed to heparinised mouse blood and were considered nonhaemolytic. The proposed IG extrusion technique can be applied in various fields requiring multilayered materials with large diameters.
- Open Access
- 8 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 12083
Translation Inhibitors Activate Autophagy Master Regulators TFEB and TFE3
The autophagy-lysosome pathway is a major protein degradation pathway stimulated by multiple cellular stresses, including nutrient or growth factor deprivation, hypoxia, misfolded proteins, damaged organelles, and intracellular pathogens. Recent studies have revealed that transcription factor EB (TFEB) and transcription factor E3 (TFE3) play a pivotal role in the biogenesis and functions of autophagosome and lysosome. Here we report that three translation inhibitors (cycloheximide, lactimidomycin, and rocaglamide A) can facilitate the nuclear translocation of TFEB/TFE3 via dephosphorylation and 14-3-3 dissociation. In addition, the inhibitor-mediated TFEB/TFE3 nuclear translocation significantly increases the transcriptional expression of their downstream genes involved in the biogenesis and function of autophagosome and lysosome. Furthermore, we demonstrated that translation inhibition increased autophagosome biogenesis but impaired the degradative autolysosome formation because of lysosomal dysfunction. These results highlight the previously unrecognized function of the translation inhibitors as activators of TFEB/TFE3, suggesting a novel biological role of translation inhibition in autophagy regulation.
- 8 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 12083
Open AccessTranslation Inhibitors Activate Autophagy Master Regulators TFEB and TFE3
The autophagy-lysosome pathway is a major protein degradation pathway stimulated by multiple cellular stresses, including nutrient or growth factor deprivation, hypoxia, misfolded proteins, damaged organelles, and intracellular pathogens. Recent studies have revealed that transcription factor EB (TFEB) and transcription factor E3 (TFE3) play a pivotal role in the biogenesis and functions of autophagosome and lysosome. Here we report that three translation inhibitors (cycloheximide, lactimidomycin, and rocaglamide A) can facilitate the nuclear translocation of TFEB/TFE3 via dephosphorylation and 14-3-3 dissociation. In addition, the inhibitor-mediated TFEB/TFE3 nuclear translocation significantly increases the transcriptional expression of their downstream genes involved in the biogenesis and function of autophagosome and lysosome. Furthermore, we demonstrated that translation inhibition increased autophagosome biogenesis but impaired the degradative autolysosome formation because of lysosomal dysfunction. These results highlight the previously unrecognized function of the translation inhibitors as activators of TFEB/TFE3, suggesting a novel biological role of translation inhibition in autophagy regulation.
- 23 September 2020
- Published by IOP Publishing in Biofabrication
- Vol. 12 (4) , 045033
Coaxial printing of double-layered and free-standing blood vessel analogues without ultraviolet illumination for high-volume vascularised tissue
Human umbilical vein endothelial cells (HUVECs) and human aortic smooth muscle cells (HASMCs) were coaxially and continuously extruded without ultraviolet illumination using a microfluidic-based nozzle. Type I collagen (3 mg ml −1 ) containing HUVECs and a crosslinking reagent (100 mM CaCl 2 ) were supplied as the core material. A mixture of 3 mg ml −1 of type I collagen (25%) and 1.8% weight volume −1 of sodium alginate (75%) was provided as the shell layer material surrounding the core material. The HUVECs were well proliferated at the core and reshaped into a monolayer formation along the axial direction of the scaffold. The HASMCs showed more than 90% cell viability in the shell layer. Fluorescent beads were passed through the inside channel of the scaffold with the HUVEC core and HASMC shell using an in-house connector. This double-layered scaffold showed higher angiogenesis in growth factor-free medium than the scaffold with only a HUVEC core. The HASMCs in the shell layer affected angiogenesis, extracellular matrix secretion, and outer diameter. The proposed technique could be applied to three-dimensional bioprinting for the production of high-volume vascularised tissue.
- 23 September 2020
- Published by IOP Publishing in Biofabrication
- Vol. 12 (4) , 045033
Coaxial printing of double-layered and free-standing blood vessel analogues without ultraviolet illumination for high-volume vascularised tissue
Human umbilical vein endothelial cells (HUVECs) and human aortic smooth muscle cells (HASMCs) were coaxially and continuously extruded without ultraviolet illumination using a microfluidic-based nozzle. Type I collagen (3 mg ml −1 ) containing HUVECs and a crosslinking reagent (100 mM CaCl 2 ) were supplied as the core material. A mixture of 3 mg ml −1 of type I collagen (25%) and 1.8% weight volume −1 of sodium alginate (75%) was provided as the shell layer material surrounding the core material. The HUVECs were well proliferated at the core and reshaped into a monolayer formation along the axial direction of the scaffold. The HASMCs showed more than 90% cell viability in the shell layer. Fluorescent beads were passed through the inside channel of the scaffold with the HUVEC core and HASMC shell using an in-house connector. This double-layered scaffold showed higher angiogenesis in growth factor-free medium than the scaffold with only a HUVEC core. The HASMCs in the shell layer affected angiogenesis, extracellular matrix secretion, and outer diameter. The proposed technique could be applied to three-dimensional bioprinting for the production of high-volume vascularised tissue.
- Open Access
- 30 December 2011
- Published by Viet Nam National University Ho Chi Minh City in Journal of Science and Technology Development
- Vol. 14 (4) , 85-93
REFOLDING, PURIFICATION AND CHARACTERIZATION OF THE RECOMBINANT hG-CSF EXPRESSED IN E. COLI
Human granulocyte colony stimulating factor (hG-CSF) is a hematopoietic growth factor produced by monocytes, fibroblasts, and endothelial cells. It stimulates the proliferation and differentiation of neutrophil precursor cells, enhancing some of the functional properties of mature neutrophils. So hG-CSF has been widely used to treat different forms of neutropenia, especially chemotherapy-induced neutropenia. In this study, we reported refolding, purification of hG-CSF expressed as inclusion body in E. coli and characterization of recombinant hG-CSF by native-PAGE and RP-HPLC chromatography showed similar yields to the standard (Neupogen). The molecular mass and peptide fragment sequence deduced from LC-MS method and the immunoassay confirmed the identity of recombinant hG-CSF. In vitro bioassay showed an equivalent biological effect (124 %) to the standard reference recombinant hG-CSF.
- 30 December 2011
- Published by Viet Nam National University Ho Chi Minh City in Journal of Science and Technology Development
- Vol. 14 (4) , 85-93
Open AccessREFOLDING, PURIFICATION AND CHARACTERIZATION OF THE RECOMBINANT hG-CSF EXPRESSED IN E. COLI
Human granulocyte colony stimulating factor (hG-CSF) is a hematopoietic growth factor produced by monocytes, fibroblasts, and endothelial cells. It stimulates the proliferation and differentiation of neutrophil precursor cells, enhancing some of the functional properties of mature neutrophils. So hG-CSF has been widely used to treat different forms of neutropenia, especially chemotherapy-induced neutropenia. In this study, we reported refolding, purification of hG-CSF expressed as inclusion body in E. coli and characterization of recombinant hG-CSF by native-PAGE and RP-HPLC chromatography showed similar yields to the standard (Neupogen). The molecular mass and peptide fragment sequence deduced from LC-MS method and the immunoassay confirmed the identity of recombinant hG-CSF. In vitro bioassay showed an equivalent biological effect (124 %) to the standard reference recombinant hG-CSF.